Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BMS-582949 hydrochloride
Cat. No.:
OB0225LY-0335
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
BMS-582949 hydrochloride is a small molecule that targets heparinase, potentially used for antitumor effects.
Synonym:
BMS-582949 HCl; 912806-16-7; 4-((5-((Cyclopropylamino)carbonyl)-2-methylphenyl)amino)-5-methyl-N-propylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide hydrochloride; 4-((5-(Cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide hydrochloride
CAS No.:
912806-16-7
Compound CID:
11848302
Formula:
C22H27ClN6O2
Formula Weight:
442.95
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BMS-582949 hydrochloride can be used in tumor biomarker studies or play an important role in drug mechanism of action studies.
Library Information
Targets:
p38 MAPK
Receptors:
p38α
Pathways:
MAPK; Autophagy
Plate Number:
AOCL-5
Plate Location:
c9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 112.88 mM
